Stock Track | STAAR Surgical Plummets 5.07% as Annual Earnings Miss Expectations

Stock Track02-13

STAAR Surgical (NASDAQ: STAA) shares plummeted 5.07% in the intraday trading session on Thursday, following the company's disappointing full-year 2024 earnings report.

The medical device maker reported a net loss of $20.2 million, or $0.41 per share, for the fiscal year 2024, marking a significant decline from the previous year's profit of $21.3 million, or $0.44 per share. Additionally, STAAR Surgical's revenue missed analyst estimates, coming in at $313.9 million, down 2.6% from the previous year.

Despite the weaker-than-expected performance, STAAR Surgical's management remains optimistic about the company's future growth prospects, forecasting a 13% annual revenue growth rate over the next three years. However, this projection falls short of the 7.9% growth forecast for the broader Medical Equipment industry in the United States.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment